A new clone sweeps clean: The enigmatic emergence of Escherichia coli sequence type 131

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 4997-5004

  Banerjee, Ritu ^a   Johnson, James R ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BETA LACTAMASE CTX M; EXTENDED SPECTRUM BETA LACTAMASE; TYPE 1 FIMBRIAL ADHESIN; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLONE; ESCHERICHIA COLI; GENETIC VARIABILITY; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; ESCHERICHIA COLI INFECTIONS; GENETICS; HUMAN; MULTIDRUG RESISTANCE; PHYLOGENY; PROCEDURES;

ANIMALS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY;

EID: 84906099443     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02824-14     Document Type: Short Survey

References (81)

1. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBL-producing enterobacteriaceae in Europe. Euro Surveill. 13:19044. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044.
2. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park Y-J, Lavigne J-P, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281. http://dx.doi.org/10.1093/jac/dkm464.
3. Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M-beta lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321. http://dx.doi.org/10.1016/j.ijantimicag. 2009.11.003.
4. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294. http://dx.doi.org/10.1086/653932.
5. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14. http://dx.doi.org/10.1093/jac/dkq415.
6. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN. 2005. An epidemic, toxin-gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441. http://dx.doi.org/10. 1056/NEJMoa051590. (Pubitemid 41770164)
7. Loo V, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault A-M, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449. http://dx.doi.org/10.1056/NEJMoa051639. (Pubitemid 41770165)
8. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. 2001. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N. Engl. J. Med. 345:1007-1013. http://dx.doi.org/10.1056/NEJMoa011265.
9. Johnson JR, Manges AR, O'Bryan TT, Riley LW. 2002. A disseminated multidrug-resistant clonal group of uropathogenic Escherichia coli in pyelonephritis. Lancet 359:2249-2251. http://dx.doi.org/10.1016/S0140-6736(02) 09264-4. (Pubitemid 34717981)
10. Johnson JR, Menard ME, Lauderdale TL, Kosmidis C, Gordon D, Collignon P, Maslow JN, Andrasević AT, Kuskowski MA, Trans-Global Initiative for Antimicrobial Resistance Analysis Investigators. 2011. Global distribution and epidemiologic associations of Escherichia coli clonal group A, 1998-2007. Emerg. Infect. Dis. 17:2001-2009. http://dx.doi.org/10.3201/eid1711.110488.
11. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200. http://dx.doi.org/10.3201/eid1402.070350. (Pubitemid 351213667)
12. Johnson JR, Clermont O, Johnston B, Clabots C, Tchesnokova V, Sokurenko E, Junka AF, Maczynska B, Denamur E. 2014. Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J. Clin. Microbiol. 52:1358-1365. http://dx.doi.org/10.1128/JCM.03502-13.
13. López-Cerero L, Navarro MD, Bellido M, Martín-Peña A, Viñas L, Cisneros JM, Gómez-Langley SL, Sánchez- Monteseirín H, Morales I, Pascual A, Rodríguez-Baño J. 2014. Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. J. Antimicrob. Chemother. 69:809-814. http://dx.doi.org/10.1093/jac/dkt405.
14. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370. http://dx.doi.org/10.1128/AAC.05824-11.
15. Colpan A, Porter S, Johnston B, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR. 2013. Escherichia coli sequence type 131 (ST131) as an emergent multidrug-resistant pathogen among U.S. veterans. Clin. Infect. Dis. 57:1256-1265. http://dx.doi.org/10.1093/cid/cit503.
16. Olesen B, Hansen DS, Nilsson F, Frimodt-Møller J, Leihof RF, Struve C, Scheutz F, Johnston B, Krogfelt KA, Johnson JR. 2013. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark. J. Clin. Microbiol. 51:1779-1785. http://dx.doi.org/10. 1128/JCM.00346-13.
17. Banerjee R, Robicsek A, Kuskowski MA, Porter S, Johnston BD, Sokurenko E, Tchesnokova V, Price LB, Johnson JR. 2013. Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007-2010. Antimicrob. Agents Chemother. 57:6385-6388. http://dx.doi.org/10.1128/AAC.01604-13.
18. Johnson JR, Nicolas-Chanoine M-H, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg. Infect. Dis. 18:598-607. http://dx.doi.org/10.3201/eid1804.111627.
19. López-Cerero L, Bellido Mdel M, Serrano L, Liró J, Cisneros JM, Rodríguez-Baño J, Pascual A. 2013. Escherichia coli O25b:H4/ST131 are prevalent in Spain and are often not associated with ESBL or quinolone resistance. Enferm. Infecc. Microbiol. Clin. 31:385-388. http://dx.doi.org/10.1016/j.eimc.2012.09.005.
20. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. 2013. Escherichia coli sequence type ST131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect. Control Hosp. Epidemiol. 34:361-369. http://dx.doi.org/10.1086/669865.
21. Adams-Sapper S, Diep BA, Perdreau-Remington F, Riley LW. 2013. Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections. Antimicrob. Agents Chemother. 57:490-497. http://dx.doi.org/10.1128/AAC.01025-12.
22. Tchesnokova V, Billig M, Chattopadhyay S, Linardopoulou E, Aprikian P, Roberts PL, Skrivankova V, Johnston B, Gileva A, Igusheva I, Toland A, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Kahl B, Price LB, Weissman SJ, Limaye A, Scholes D, Johnson JR, Sokurenko EV. 2013. Predictive diagnostics of Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J. Clin. Microbiol. 51:2991-2999. http://dx.doi.org/10.1128/JCM.00984-13.
23. Williamson DA, Freeman JT, Porter S, Roberts S, Wiles S, Paterson DL, Johnson JR. 2013. Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. J. Antimicrob. Chemother. 68:2898-2906. http://dx.doi.org/10.1093/jac/dkt276.
24. Chung H-C, Lai C-H, Lin J-N, Huang C-K, Liang S-H, Chen W-F, Shih Y-C, Lin H-H, Wang J-L. 2012. Bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob. Agents Chemother. 56:618-622. http://dx.doi.org/10.1128/AAC.05753- 11.
25. Doi Y, Park YS, Rivera JI, Adams-Haduch JM, Hingwe A, Sordillo EM, Lewis JS, Howard WJ, Johnson LE, Polsky B, Jorgensen JH, Richter SS, Shutt KA, Paterson DL. 2013. Community-associated extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli infection in the United States. Clin. Infect. Dis. 56:641-648. http://dx.doi.org/10.1093/cid/cis942.
26. Banerjee R, Strahilevitz J, Johnson JR, Nagwekar PP, Schora DM, Shevrin I, Du H, Peterson LR, Robicsek A. 2013. Predictors and molecular epidemiology of community-onset extended-spectrum betalactamase (ESBL)-producing Escherichia coli infection in a Midwestern community. Infect. Control Hosp. Epidemiol. 34:947-953. http://dx.doi.org/10.1086/671725.
27. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. 2008. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J. Clin. Microbiol. 46:2605-2612. http://dx.doi.org/10.1128/JCM.00640-08.
28. Banerjee R, Johnston B, Lohse C, Chattopadhyay S, Tchesnokova V, Sokurenko EV, Johnson JR. 2013. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob. Agents Chemother. 57:5912-5917. http://dx.doi.org/10.1128/AAC.01065-13.
29. Burke L, Humphreys H, Fitzgerald-Hughes D. 2012. The revolving door between hospital and community: extended-spectrum beta-lactamase-producing Escherichia coli in Dublin. J. Hosp. Infect. 81:192-198. http://dx.doi.org/10. 1016/j.jhin.2012.04.021.
30. Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM. 2009. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 64:635-641. http://dx.doi.org/10. 1093/jac/dkp220.
31. Nicolas-Chanoine MH, Jarlier V, Robert J, Arlet G, Drieux L, Leflon-Guibout V, Laouénan C, Larroque B, Caro V, Mentré F, Group Coli β. 2012. Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study. PLoS One 7:e30498. http://dx.doi.org/10.1371/journal.pone.0030498.
32. van der Donk CF, Schols JM, Driessen CJ, Hagenouw RG, Meulendijks A, Stobberingh EE. 2013. Prevalence and spread of multidrug resistant Escherichia coli isolates among nursing home residents in the southern part of The Netherlands. J. Am. Med. Dir. Assoc. 14:199-203. http://dx.doi.org/10.1016/j. jamda.2012.09.026.
33. Nicolas-Chanoine M-H, Robert J, Vigan M, Laoenan C, Brisse S, Mentre F, Jarlier V. 2013. Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates. PLoS One 8:e72191. http://dx.doi.org/10.1371/journal.pone.0072191.
34. Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentre F, Jarlier V, Nicolas-Chanoine MH. 2012. Phylogenetic distribution of CTX-M and non-extended-spectrum beta-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 50:2974-2981. http://dx.doi.org/10.1128/JCM. 00919-12.
35. Pitout JDD, Campbell L, Church DL, Gregson DB, Laupland KB. 2009. Molecular characteristics of travel-related extended-spectrum-beta-lactamase- producing Escherichia coli isolates from the Calgary Health Region. Antimicrob. Agents Chemother. 53:2539-2543. http://dx.doi.org/10.1128/AAC.00061-09.
36. Vasoo S, Madigan T, Cunningham SA, Mandrekar JN, Porter SB, Johnston B, Sampathkumar P, Tosh PK, Johnson JR, Patel R, Banerjee R. 2014. Prevalence of rectal colonization with multidrug-resistant Enterobacteriaceae among international patients hospitalized at Mayo Clinic, Rochester, Minnesota. Infect. Control Hosp. Epidemiol. 35:182-186. http://dx.doi.org/10.1086/674853.
37. Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, Ellis-Pegler RB. 2008. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin. Infect. Dis. 47:689-692. http://dx.doi.org/10.1086/590941.
38. Vignaroli C, Luna GM, Pasquaroli S, Cesare Di A, Petruzzella R, Paroncini P, Biavasco F. 2013. Epidemic Escherichia coli ST131 and Enterococcus faecium ST17 in coastal marine sediments from an Italian beach. Environ. Sci. Technol. 47:13772-13780. http://dx.doi.org/10.1021/es4019139.
39. Colomer-Lluch M, Mora A, López C, Mamani R, Dahbi G, Marzoa J, Herrera A, Viso S, Blanco JE, Blanco M, Alonso MP, Jofre J, Muniesa M, Blanco J. 2013. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-DST69 in raw sewage and river water in Barcelona, Spain. J. Antimicrob. Chemother. 68:758-765. http://dx.doi.org/10. 1093/jac/dks477.
40. Vredenburg J, Varela AR, Hasan B, Bertilsson S, Olsen B, Narciso-da-Rocha C, Bonnedahl J, Stedt J, Da Costa PM, Manaia CM. 27 August 2013. Quinolone-resistant Escherichia coli isolated from birds of prey in Portugal are genetically distinct from those isolated from water environments and gulls in Portugal, Spain, and Sweden. Environ. Microbiol. http://dx.doi.org/10.1111/1462- 2920.12231.
41. Zurfluh K, Hachler H, Nuesch-Inderbinen M, Stephan R. 2013. Characteristics of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae isolates from rivers and lakes in Switzerland. Appl. Environ. Microbiol. 79:3021-3026. http://dx.doi.org/10.1128/AEM.00054-13.
42. Platell JL, Johnson JR, Cobbold RN, Trott DJ. 2011. Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods. Vet. Microbiol. 153:99-108. http://dx.doi.org/10.1016/j.vetmic.2011. 05.007.
43. Manges AR, Johnson JR. 2012. Food-borne origins of Escherichia coli causing extraintestinal infections. Clin. Infect. Dis. 55:712-719. http://dx.doi.org/10.1093/cid/cis502.
44. Johnson JR, Tchesnokova V, Johnston B, Clabots C, Roberts PL, Billig M, Riddell K, Rogers P, Qin X, Butler-Wu S, Price LB, Aziz M, Nicolas-Chanoine MH, Debroy C, Robicsek A, Hansen G, Urban C, Platell J, Trott DJ, Zhanel G, Weissman SJ, Cookson BT, Fang FC, Limaye AP, Scholes D, Chattopadhyay S, Hooper DC, Sokurenko EV. 2013. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J. Infect. Dis. 207:919-928. http://dx.doi.org/10. 1093/infdis/jis933.
45. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. 2011. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J. Antimicrob. Chemother. 66:2501-2508. http://dx.doi.org/10.1093/jac/dkr349.
46. Liss MR, Peterson EM, Johnston B, Osann K, Johnson JR. 2013. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy. Urology 81:548-556. http://dx.doi.org/10.1016/j.urology.2012.10.056.
47. Weissman SJ, Johnson JR, Tchesnokova V, Billig M, Dykhuizen D, Riddell K, Rogers P, Qin X, Butler-Wu S, Cookson BT, Fang FC, Scholes D, Chattopadhyay S, Sokurenko E. 2012. High resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl. Environ. Microbiol. 78:1353-1360. http://dx.doi.org/10.1128/AEM.06663-11.
48. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Pearson T, Keim P, Sokurenko EV. 2013. Epidemic clonal expansion of CTX-M-15-producing Escherichia coli ST131. mBio 4:e00377-13. http://dx.doi.org/10.1128/mBio.00377-13.
49. Petty NK, Zakour Ben NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Moriel Gomes D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Bano J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc. Natl. Acad. Sci. U. S. A. 111:5694-5699. http://dx.doi.org/ 10.1073/pnas.1322678111.
50. Matsumura Y, Yamamoto M, Nagao M, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S. 2012. Emergence and spread of B2-ST131-O25b, B2-ST131-O16, and D-ST405 clonal groups among extended-spectrum beta-lactamase-producing Escherichia coli in Japan. J. Antimicrob. Chemother. 67:2612-2620. http://dx.doi.org/10.1093/jac/dks278.
51. Matsumura Y, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S. 2013. Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-beta-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 clonal groups. Antimicrob. Agents Chemother. 57:4736-4742. http://dx.doi.org/10.1128/AAC.00641-13.
52. Mora A, Dahbi G, López C, Mamani R, Marzoa J, Dion S, Picard B, Blanco M, Alonso MP, Denamur E, Blanco J. 30 January 2014. Virulence patterns in a murine sepsis model of ST131 Escherichia coli clinical isolates belonging to serotypes O25b:H4 and O16:H5 are associated to specific virotypes. PLoS One http://dx.doi.org/10.1371/journal.pone.0087025.
53. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. 2010. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr. Infect. Dis. J. 29:473-475. http://dx.doi.org/10.1097/INF.0b013e3181c89bd7.
54. Owens RC, Johnson JR, Stogsdill P, Yarmus L, Lolans K, Quinn J. 2011. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J. Clin. Microbiol. 49:3406-3408. http://dx.doi.org/10.1128/JCM.00993-11.
55. Andersen PS, Stegger M, Aziz M, Contente-Cuomo T, Gibbons HS, Keim P, Sokurenko EV, Johnson JR, Price LB. 2013. Complete genome sequence of the epidemic and highly virulent CTX-M-15 producing H30-Rx subclone of Escherichia coli ST131. Genome Announc. 1:e00988-13. http://dx.doi.org/10.1128/genomeA. 00988-13.
56. Ender PT, Gajanana D, Johnston B, Clabots C, Tamarkin FJ, Johnson JR. 2009. Transmission of an extended-spectrum beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J. Clin. Microbiol. 47:3780-3782. http://dx.doi.org/10.1128/JCM.01361-09.
57. Johnson JR, Miller S, Johnston B, Clabots C, DebRoy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725. http://dx.doi.org/10.1128/JCM.01581-09.
58. Blanc V, Leflon-Guibout V, Blanco J, Haenni M, Madec J-Y, Rafignon G, Bruno P, Mora A, Lopez C, Dahbi G, Dunais B, Anastay M, Branger C, Moreau R, Pradier C, Nicolas-Chanoine M-H. 8 January 2014. Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains. J. Antimicrob. Chemother. http://dx.doi.org/ 10.1093/jac/dkt519.
59. Reves RR, Fong M, Pickering LK, Bartlett A, III, Alvarez M, Murray BE. 1990. Risk factors for fecal colonization with trimethoprim-resistant and multiresistant Escherichia coli among children in day-care centers in Houston, Texas. Antimicrob. Agents Chemother. 34:1429-1434. http://dx.doi.org/10.1128/ AAC.34.7.1429. (Pubitemid 20215787)
60. Lietzau S, Raum E, von Baum H, Marre R, Brenner H. 2006. Clustering of antibiotic resistance of E. coli in couples: suggestion for a major role of conjugal transmission. BMC Infect. Dis. 6:119. http://dx.doi.org/10.1186/1471- 2334-6-119.
61. Lietzau S, Raum E, von Baum H, Marre R, Brenner H. 2007. Household contacts were key factor for children's colonization with resistant Escherichia coli in community setting. J. Clin. Epidemiol. 60:1149-1155. http://dx.doi.org/10.1016/j.jclinepi.2007.01.016. (Pubitemid 47552762)
62. Hannah EL, Angulo FJ, Johnson JR, Haddadin B, Williamson J, Samore MH. 2005. Drug-resistant Escherichia coli, rural Idaho. Emerg. Infect. Dis. 11:1614-1617. http://dx.doi.org/10.3201/eid1110.050140. (Pubitemid 41384354)
63. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. 1997. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 157:1127-1129. http://dx.doi.org/10.1016/ S0022-5347(01)65154-1. (Pubitemid 27066330)
64. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon J-M, Garry L, Clermont O, Denamur E, Vandewalle A. 2012. The CTX-M-15-producing Escherichia coli clone O25b:H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. http://dx.doi.org/10.1371/journal.pone.0046547.
65. Nicolas-Chanoine M-H, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Berg F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V. 2013. 10-Fold increase (2006-2011) in the rate of healthy subjects with extended-spectrum beta-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J. Antimicrob. Chemother. 68:562-568. http://dx.doi.org/10.1093/jac/dks429.
66. Birgy A, Mariani-Kurkdjian P, Bidet P, Doit C, Genel N, Courroux C, Arlet G, Bingen E. 2013. Characterization of extended-spectrum-beta-lactamase- producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131. J. Clin. Microbiol. 51:1727-1732. http://dx.doi.org/10.1128/JCM.03255-12.
67. Kudinha T, Johnson JR, Andrew SC, Kong F, Anderson P, Gilbert GL. 2013. Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women. J. Clin. Microbiol. 51:3270-3276. http://dx.doi.org/10.1128/JCM.01315-13.
68. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers. Pediatr. Infect. Dis. J. 32:543-548. http://dx.doi.org/10.1097/INF.0b013e31828ba3f1.
69. Kudinha T, Johnson JR, Andrew SD, Kong F, Anderson P, Gilbert GL. 2013. Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls. Clin. Microbiol. Infect. 19:E173-E180. http://dx.doi.org/10.1111/1469-0691.12123.
70. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, Herrera A, Marzoa J, Fernández V, de la Cruz F, Martínez-Martínez L, Alonso MP, Nicolas-Chanoine MH, Johnson JR, Johnston B, López-Cerero L, Pascual A, Rodríguez-Baño J, Spanish Group for Nosocomial Infections (GEIH). 2013. Four main virotypes among extended-spectrum-β- lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. J. Clin. Microbiol. 51:3358-3357. http://dx.doi.org/10.1128/JCM.01555-13.
71. Alhashash F, Weston V, Diggle M, McNally A. 2013. Multidrug-resistant Escherichia coli bacteremia. Emerg. Infect. Dis. 19:1699-1701. http://dx.doi.org/10.3201/eid1910.130309.
72. Lefort A, Panhard X, Clermont O, Woerther P-L, Branger C, Mentre F, Fantiin B, Wolff M, Denamur E. 2011. Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J. Clin. Microbiol. 49:777-783. http://dx.doi.org/10.1128/JCM.01902-10.
73. Lavigne J-P, Bergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicholas-Chanoine M-H. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. http://dx.doi.org/10.1371/journal.pone.0034294.
74. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028. http://dx.doi.org/10.1093/jac/dkn084. (Pubitemid 351524443)
75. Johnson JR, Porter SB, Zhanel G, Kuskowski MA, Denamur E. 2012. Virulence of Escherichia coli clinical isolates in a murine sepsis model in relation to sequence type ST131 status, fluoroquinolone resistance, and virulence genotype. Infect. Immun. 80:1554-1562. http://dx.doi.org/10.1128/IAI.06388-11.
76. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon J-M, Fernandez B, Hertig A, Rondeau E, Arlet G, Hornet MW, Vandewalle A. 2008. TLR4 facilitates translocation of bacteria across renal collecting duct cells. J. Am. Soc. Nephrol. 19:2364-2374. http://dx.doi.org/10.1681/ASN.2007121273.
77. Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentre F. 2009. Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. J. Infect. Dis. 200:390-398. http://dx.doi.org/10.1086/ 600122.
78. Andraud M, Rose N, Laurentie M, Sanders P, LeRoux A, Cariolet R, Chauvin C, Jouy E. 2011. Estimation of transmission parameters of a fluoroquinolone- resistant Escherichia coli strain between pigs in experimental conditions. Vet. Res. 42:44. http://dx.doi.org/10.1186/1297-9716-42-44.
79. Lautenbach E. 2013. Flying under the radar: the stealth pandemic of Escherichia coli sequence type 131. Clin. Infect. Dis. 57:1266-1269. http://dx.doi.org/10.1093/cid/cit505.
80. Dumford D, Suwantarat N, Bhasker V, Kundrapu S, Zabarsky TF, Drawz P, Zhu H, Donskey CJ. 2013. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate. Infect. Control Hosp. Epidemiol. 34:269-273. http://dx.doi.org/10.1086/669512.
81. Chattopadhyay S, Taub F, Paul S, Weissman SJ, Sokurenko EV. 2013. Microbial variome database: point mutations, adaptive or not, in bacterial core genomes. Mol. Biol. Evol. 30:1465-1470. http://dx.doi.org/10.1093/molbev/mst048.